The Transfection Technologies Market is expected to reach USD 1.12 billion by 2024, growing at a CAGR of 9.12% during the forecast period 2019-2024. The rising research & development in the field of cell based therapies, and huge investments by government and private players, and rising incidences of cancer are some of the factors propelling the growth of the market.
Transfection Technologies Market (Calcium Phosphate, Lipofection, Nucleofection, Magnetofection, Electroporation, Viral, Gene Gun) And Types (DNA Delivery, Gene Delivery, Protein Delivery, SiRNA Delivery) – 2023 to 2028
$3,850.00 – $5,850.00
Published on: January 23, 20231 Global Transfection Technologies Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Transfection Technologies Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Transfection Technologies Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Transfection Technologies Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Transfection Technologies Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Challenges
6.2.3 Opportunities
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Transfection Technologies Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Transfection Technologies Market – By Type (Market Size – & million/billion)
8.1 Cotransfection
8.2 Electroporation
8.3 Cationic Lipid Transfection
8.4 In Vivo Transfection
9 Global Transfection Technologies Market – By Application
9.1 Protein production
9.2 Gene silencing
9.3 Virus production
9.4 Stem cell reprogramming & differentiation
9.5 Stable cell line generation
10 Global Transfection Technologies Market – By Geography (Market Size – & million/billion)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 U.K
10.3.2 Germany
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia-Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Rest of the World
10.5.1 South America
10.5.2 Middle East
10.5.3 Africa
11 Global Transfection Technologies Market – Entropy
11.1 New product launches
11.2 M&A’s, collaborations, JVs and partnerships
12 Global Transfection Technologies Market Company Profile (Key Players)
12.1 Market Share, Company Revenue, Products, M&A, Developments
12.2 Qiagen
12.3 Promega
12.4 Polyplus
12.5 Lonza
12.6 Bio-Rad
12.7 Roche
12.8 Life Technologies
12.9 SignaGen
12.10 Sigma Aldrich
12.11 Thermo Fisher
12.12 Company 11 & more
13 Global Transfection Technologies Market – Appendix
13.1 Sources
13.2 Abbreviations